Preprint · CC-BY
via OpenAlex
Drosophila melanogaster in the Study of Human Neurodegeneration
CNS & Neurological Disorders - Drug Targets · 2010 · ▲ 247 citations
Abstract
Human neurodegenerative diseases are devastating illnesses that predominantly affect elderly people. The majority of the diseases are associated with pathogenic oligomers from misfolded proteins, eventually causing the formation of aggregates and the progressive loss of neurons in the brain and nervous system. Several of these proteinopathies are sporadic and the cause of pathogenesis remains elusive. Heritable forms are associated with genetic defects, suggesting that the affected protein is causally related to disease formation and/or progression. The limitations of human genetics, however, make it necessary to use model systems to analyse affected genes and pathways in more detail. During the last two decades, research using the genetically amenable fruitfly has established Drosophila melanogaster as a valuable model system in the study of human neurodegeneration. These studies offer reliable models for Alzheimer's, Parkinson's, and motor neuron diseases, as well as models for trinucleotide repeat expansion diseases, including ataxias and Huntington's disease. As a result of these studies, several signalling pathways including phosphatidylinositol 3-kinase (PI3K)/Akt and target of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) (TOR), c-Jun N-terminal kinase (JNK) and bone morphogenetic protein (BMP) signalling, have been shown to be deregulated in models of proteinopathies, suggesting that two or more initiating events may trigger disease formation in an age-related manner. Moreover, these studies also demonstrate that the fruitfly can be used to screen chemical compounds for their potential to prevent or ameliorate the disease, which in turn can directly guide clinical research and the development of novel therapeutic strategies for the treatment of human neurodegenerative diseases.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.2174/187152710791556104
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Hirth, F. (2010). Drosophila melanogaster in the Study of Human Neurodegeneration. <em>CNS & Neurological Disorders - Drug Targets</em>. https://doi.org/10.2174/187152710791556104
Vancouver
Hirth F. Drosophila melanogaster in the Study of Human Neurodegeneration. CNS & Neurological Disorders - Drug Targets. 2010. doi:10.2174/187152710791556104.
BibTeX
@unpublished{frank2010Drosop,
title = {Drosophila melanogaster in the Study of Human Neurodegeneration},
author = {Frank Hirth},
journal = {CNS & Neurological Disorders - Drug Targets},
year = {2010},
doi = {10.2174/187152710791556104},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Pharmacological Reviews 2011
Open access · OA
Human Disease Models in Drosophila melanogaster and the Role of the Fly in Therapeutic Drug Discovery
Nature immunology 2026
Citation only
Adaptive immunity in the pathogenesis of neurodegeneration.
Antioxidants and Redox Signaling 2014
Preprint · OA
The Ubiquitin-Proteasome System in Neurodegeneration
Journal of Ethnopharmacology 2019
Citation only
Ginseng protein protects against mitochondrial dysfunction and neurodegeneration by inducing mitochondrial unfolded protein response in Drosophila melanogaster PINK1 model of Parkinson's disease
Frontiers in Aging 2025
Open access · CC-BY
Editorial: Aging and neurodegeneration in the brain
Journal of Neurodegenerative Diseases 2012
Open access · CC-BY